Ericsson alongside its Swedish health-tech partner Brighter has introduced Actiste, which is claimed to be the world's first complete Internet of Things (IoT) solution for monitoring and treating insulin-dependent diabetes.
The introduction of the commercially ready solution was announced at the recently concluded GITEX Technology Week with Brighter now ready to deliver Actiste as a service in the UAE and GCC. It brings together all required functions into a single connected device which is capable of blood sampling, blood glucose measurement and insulin injection. The device is designed to be delivered as part of a subscription service, designed to simplify a patient's everyday life.
In the UAE, there are currently 1.2 million people living with diabetes of which 480,000 are insulin-dependent. For those, Brighter's Actiste service could be beneficial. Henrik Norström, the CEO of Brighter says “By partnering with Ericsson, we are able to offer a truly seamless customer experience. No matter where in the world patients decide to go, their generated health and treatment data will always be securely stored and available to improve their treatments.”
The cellular-enabled Actiste devices are managed by Ericsson's IoT accelerator and are securely connected by leading communications service providers to deliver a consistent level of service and a single dashboard. The gives Brighter a unified view regardless of where those devices are deployed in the world.